Correlation Between Adaptimmune Therapeutics and Celldex Therapeutics
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Celldex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Celldex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Celldex Therapeutics, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Celldex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Celldex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Celldex Therapeutics.
Diversification Opportunities for Adaptimmune Therapeutics and Celldex Therapeutics
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Adaptimmune and Celldex is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Celldex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celldex Therapeutics and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Celldex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celldex Therapeutics has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Celldex Therapeutics go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and Celldex Therapeutics
Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to generate 0.99 times more return on investment than Celldex Therapeutics. However, Adaptimmune Therapeutics Plc is 1.01 times less risky than Celldex Therapeutics. It trades about -0.1 of its potential returns per unit of risk. Celldex Therapeutics is currently generating about -0.16 per unit of risk. If you would invest 58.00 in Adaptimmune Therapeutics Plc on November 27, 2024 and sell it today you would lose (3.00) from holding Adaptimmune Therapeutics Plc or give up 5.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. Celldex Therapeutics
Performance |
| Timeline |
| Adaptimmune Therapeutics |
| Celldex Therapeutics |
Adaptimmune Therapeutics and Celldex Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptimmune Therapeutics and Celldex Therapeutics
The main advantage of trading using opposite Adaptimmune Therapeutics and Celldex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Celldex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celldex Therapeutics will offset losses from the drop in Celldex Therapeutics' long position.The idea behind Adaptimmune Therapeutics Plc and Celldex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Celldex Therapeutics vs. Ideaya Biosciences | Celldex Therapeutics vs. AnaptysBio | Celldex Therapeutics vs. MeiraGTx Holdings PLC | Celldex Therapeutics vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |